Neurodyn

About:

Neurodyn identifies, validates, and develops bioactive for neuroprotection and the early treatment of neurological diseases.

Website: http://www.neurodyn.ca

Description:

Neurodyn identifies, validates, and develops bioactive for neuroprotection and the early treatment of neurological diseases. Its product pipeline comprises ND-1004, a natural product based neuro-protectant for early-stage treatment of Parkinson's disease. It was founded in 2009 and is headquartered in Vancouver, British Columbia.

Total Funding Amount:

$2.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Vancouver, British Columbia, Canada

Founded Date:

2009-01-01

Founders:

Denis Kay

Number of Employees:

11-50

Last Funding Date:

2016-04-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai